Setting a Global Example: Three Accredited Next Generation Sequencing Platforms Under One Roof

(PresseBox) ( Konstanz, Germany, )
With official accreditation of yet another sequencing platform, GATC Biotech presents the worldwide first trio of accredited NGS platforms under one roof. After successful accreditation the technology platforms Ilumina HiSeq and Roche GS FLX, the high quality of PacBio RS sequencing has now officially been confirmed by the national accreditation body for the Federal Republic of Germany (DAkkS).

The combination of three accredited Next Generation Sequencing platforms under one roof is said to be unique globally. The Pacific Biosciences PacBio RS platform located at GATC Biotech's headquarter has been officially accredited according to EN ISO/IEC 17025. The accreditation of PacBio RS adds an extensive variety of efficiency and quality to the pre-high-quality fleet of different platforms. Thereby, the company achieves maximum exhaustion of all Next Gen Systems available within its own laboratory.

Being Europe's first sequencing provider to use the PacBio RS platform, GATC Biotech emphasises its position on the international sequencing market. The third accreditation within one year demonstrates the latest state-of-the-art standards in the company's methods, technologies and data quality that are pursued by responsible staff members at all times.

As Dr. Marcus Benz, COO of GATC Biotech AG, explains:"The flexible accreditation of various platforms allows our customers to benefit from the firsthand and experienced support and to rely on an all-time audited international quality standard."
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.